STAT3 regulates the growth and immunoglobulin production of BCL1 B cell lymphoma through control of cell cycle progression

被引:23
作者
Karras, JG
McKay, RA
Lu, T
Pych, J
Frank, DA
Rothstein, TL
Monia, BP
机构
[1] ISIS Pharmaceut, Dept Mol & Cellular Pharmacol, Carlsbad, CA 92008 USA
[2] Boston Med Ctr, Dept Med & Microbiol, Boston, MA 02118 USA
[3] Boston Med Ctr, Evans Mem Dept Clin Res, Boston, MA 02118 USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Div Adult Oncol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
B lymphocytes; signal transduction; cell cycle; molecular biology; Jak-STAT pathway;
D O I
10.1006/cimm.2000.1661
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
STAT3 is constitutively phosphorylated on tyrosine(705) in self-renewing, CD5(+) murine B-1 lymphocytes, Nuclear extracts from untreated primary B-l or CD5(+) BCL1 B lymphoma cells were found to contain immunoreactive STAT3 protein that binds to a sis-inducible element present in the promoter of the p21(waf1/cip1) tumor suppressor gene and is constitutively phosphorylated on serine(727). To determine the functional significance of constitutive STAT3 activation in B lymphoma cells, a specific STAT3 antisense oligonucleotide was developed and used to examine basal BCL1 cell growth and IgM production. Abrogating STAT3 expression in BCL1 cells inhibited their proliferative capacity and induced a corresponding decrease in secretion of IgM, Cell cycle analysis showed a block in progression through G1 in BCL1 cells treated with the STAT3 antisense oligonucleotide, These results indicate that STATE controls cell growth and immunoglobulin secretion by enhancing progression through the G1 phase of the cell cycle in BCL1 B cell lymphoma, (C) 2000 Academic Press.
引用
收藏
页码:124 / 135
页数:12
相关论文
共 76 条
[1]   MOLECULAR-CLONING OF APRF, A NOVEL IFN-STIMULATED GENE FACTOR-3 P91-RELATED TRANSCRIPTION FACTOR INVOLVED IN THE GP130-MEDIATED SIGNALING PATHWAY [J].
AKIRA, S ;
NISHIO, Y ;
INOUE, M ;
WANG, XJ ;
WEI, S ;
MATSUSAKA, T ;
YOSHIDA, K ;
SUDO, T ;
NARUTO, M ;
KISHIMOTO, T .
CELL, 1994, 77 (01) :63-71
[2]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[3]   STAT3 ACTIVATION BY CYTOKINES UTILIZING GP130 AND RELATED TRANSDUCERS INVOLVES A SECONDARY MODIFICATION REQUIRING AN H7-SENSITIVE KINASE [J].
BOULTON, TG ;
ZHONG, Z ;
WEN, ZL ;
DARNELL, JE ;
STAHL, N ;
YANCOPOULOS, GD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6915-6919
[4]   B-LYL CELLS - IMMORTAL LY-1+ LYMPHOCYTE-B CELL-LINES SPONTANEOUSLY ARISING IN MURINE SPLENIC CULTURES [J].
BRAUN, J ;
CITRI, Y ;
BALTIMORE, D ;
FOROUZANPOUR, F ;
KING, L ;
TEHERANIZADEH, K ;
BRAY, M ;
KLIEWER, S .
IMMUNOLOGICAL REVIEWS, 1986, 93 :5-21
[5]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[6]   Stat3 activation is required for cellular transformation by v-src [J].
Bromberg, JF ;
Horvath, CM ;
Besser, D ;
Lathem, WW ;
Darnell, JE .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) :2553-2558
[7]   MONOREACTIVE HIGH-AFFINITY AND POLYREACTIVE LOW AFFINITY RHEUMATOID FACTORS ARE PRODUCED BY CD5+ B-CELLS FROM PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
BURASTERO, SE ;
CASALI, P ;
WILDER, RL ;
NOTKINS, AL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) :1979-1992
[8]   INFREQUENT NORMAL LYMPHOCYTES-B EXPRESS FEATURES OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
CALIGARISCAPPIO, F ;
GOBBI, M ;
BOFILL, M ;
JANOSSY, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (02) :623-628
[9]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[10]  
Chai SK, 1997, J IMMUNOL, V159, P4720